Seltene chirurgische Tumoren im biliopankreatoduodenalen Bereich

Gastrointestinale Stromatumoren, Choledochuszysten und pankreatische neuroendokrine Tumoren sind seltene Tumoren des biliopankreatoduodenalen Bereichs. Eine frühzeitige Diagnose ist entscheidend für die Prognose und das Überleben der betroffenen Patienten. Dieser Beitrag gibt einen Überblick über das diagnostische Vorgehen und die therapeutischen Optionen.

Schlüsselwörter

gastrointestinale Stromatumoren - Choledochuszysten - pankreatische neuroendokrine Tumoren - Therapie

• Literatur

• 1 Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983; 7: 507-519
• 2 Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet 2013; 382: 973-983
• 3 Reichardt P, Bauer S, Dürr D. et al. Gastrointestinale Stromatumoren (GIST). Onkopedia-Leitlinie. Im Internet (Stand: 24.11.2021): http://www.onkopedia.com/de/onkopedia/guidelines/gastrointestinale-stromatumoren-gist/@@guideline/html/index.html%23ID0EKC%22%3ehttps://%3cDCCnv::EMAIL%3ewww.onkopedia.com/de/onkopedia/guidelines/gastrointestinale-stromatumoren-gist/@@guideline/html/index.html%23ID0EKC
• 4 Demetri GD, Benjamin RS, Blanke CD. et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST) – update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 2007; 5 (Suppl. 02) S1-S29 quiz S30
• 5 Joensuu H, Vehtari A, Riihimäki J. et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 2012; 13: 265-274
• 6 Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83
• 7 Feng F, Liu Z, Zhang X. et al. Comparison of Endoscopic and Open Resection for Small Gastric Gastrointestinal Stromal Tumor. Transl Oncol 2015; 8: 504-508
• 8 Wang C, Gao Z, Shen K. et al. Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: A systematic review and meta-analysis. Eur J Surg Oncol 2020; 46: 667-674
• 9 Onimaru M, Inoue H, Ikeda H. et al. Combination of laparoscopic and endoscopic approaches for neoplasia with non-exposure technique (CLEAN-NET) for gastric submucosal tumors: updated advantages and limitations. Ann Transl Med 2019; 7: 582
• 10 Demetri GD, von Mehren M, Blanke CD. et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472-480
• 11 Machairas N, Prodromidou A, Molmenti E. et al. Management of liver metastases from gastrointestinal stromal tumors: where do we stand?. J Gastrointest Oncol 2017; 8: 1100-1108
• 12 Oppelt PJ, Hirbe AC, Van Tine BA. Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review. J Gastrointest Oncol 2017; 8: 466-473
• 13 Miettinen M, Makhlouf H, Sobin LH. et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006; 30: 477-489
• 14 Ronnekleiv-Kelly SM, Soares KC, Ejaz A. et al. Management of choledochal cysts. Curr Opin Gastroenterol 2016; 32: 225-231
• 15 Söreide K, Körner H, Havnen J. et al. Bile duct cysts in adults. Br J Surg 2004; 91: 1538-1548
• 16 Cheng SP, Yang TL, Jeng KS. et al. Choledochal cyst in adults: aetiological considerations to intrahepatic involvement. ANZ J Surg 2004; 74: 964-967
• 17 Alonso-Lej F, Rever jr. WB, Pessagno DJ. Congenital choledochal cyst, with a report of 2, and an analysis of 94, cases. Int Abstr Surg 1959; 108: 1-30
• 18 Todani T, Watanabe Y, Tabuchi K. et al. Congenital bile duct cysts: Classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 1977; 134: 263-269
• 19 Lee SE, Jang JY, Lee YJ. et al. Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg 2011; 146: 1178-1184
• 20 Soares KC, Arnaoutakis DJ, Kamel I. et al. Choledochal cysts: presentation, clinical differentiation, and management. J Am Coll Surg 2014; 219: 1167-1180
• 21 Soreide K, Soreide JA. Bile duct cyst as precursor to biliary tract cancer. Ann Surg Oncol 2007; 14: 1200-1211
• 22 Xia HT, Yang T, Liang B. et al. Treatment and outcomes of adults with remnant intrapancreatic choledochal cysts. Surgery 2016; 159: 418-425
• 23 Edil BH, Cameron JL, Reddy S. et al. Choledochal cyst disease in children and adults: a 30-year single-institution experience. J Am Coll Surg 2008; 206: 1000-1005 discussion 1005–1008
• 24 Soares KC, Kim Y, Spolverato G. et al. Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults: A Multi-institutional Analysis. JAMA Surg 2015; 150: 577-584
• 25 Patel N, Benipal B. Incidence of Cholangiocarcinoma in the USA from 2001 to 2015: A US Cancer Statistics Analysis of 50 States. Cureus 2019; 11: e3962
• 26 Perri G, Prakash LR, Katz MHG. Pancreatic neuroendocrine tumors. Curr Opin Gastroenterol 2019; 35: 468-477
• 27 Ben Q, Zhong J, Fei J. et al. Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study. Sci Rep 2016; 6: 36073
• 28 Giraldi L, Vecchioni A, Carioli G. et al. Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control study. Endocrine 2021; 71: 233-241
• 29 Falconi M, Eriksson B, Kaltsas G. et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology 2016; 103: 153-171
• 30 Worhunsky DJ, Krampitz GW, Poullos PD. et al. Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB (Oxford) 2014; 16: 304-311
• 31 Hashim YM, Trinkaus KM, Linehan DC. et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg 2014; 259: 197-203
• 32 Kuo EJ, Salem RR. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann Surg Oncol 2013; 20: 2815-2821
• 33 Galleberg RB, Knigge U, Janson ET. et al. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas. Eur J Surg Oncol 2017; 43: 1682-1689
• 34 Pavel M, OʼToole D, Costa F. et al. ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology 2016; 103: 172-185
• 35 Kennedy AS. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors. Hematol Oncol Clin North Am 2016; 30: 193-207
• 36 Partelli S, Bartsch DK, Capdevila J. et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours. Neuroendocrinology 2017; 105: 255-265
• 37 Garcia-Carbonero R, Sorbye H, Baudin E. et al. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology 2016; 103: 186-194
• 38 Dasari A, Shen C. Halperin. et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 2017; 3: 1335-1342
• 39 Strosberg JR, Cheema A, Weber J. et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol 2011; 29: 3044-3049
• 40 Landoni L, Marchegiani G, Pollini T. et al. The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. Ann Surg 2019; 269: 725-732
• 41 Jensen RT, Cadio G, Brandi ML. et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 2012; 95: 98-119
• 42 Norton JA, Foster DS, Ito T. et al. Gastrinomas: Medical or Surgical Treatment. Endocrinol Metab Clin North Am 2018; 47: 577-601
• 43 Norton JA, Fraker DL, Alexander HR. et al. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome. Ann Surg 2012; 256: 509-517
• 44 Norton JA, Foster DS, Blumgart LH. et al. Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract. JAMA Surg 2018; 153: e175083